Blood pressure, stroke, and coronary heart disease

The Lancet - Tập 335 Số 8693 - Trang 827-838 - 1990
Rory Collins1, Richard Peto1, Stephen MacMahon1, Patricia R. Hebert2, Nicholas H. Fiebach3, Kimberley A. Eberlein2, J Godwin1, Nawab Qizilbash1, James O. Taylor2
1MRC/ICRF Clinical Trial Service Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford, UK
2Channing Laboratory, Department of Medicine, Brigham & Women's Hospital, Boston, U.S.A.
3Department of Medicine, Yale University, New Haven, CT (U.S.A.)

Tóm tắt

Từ khóa


Tài liệu tham khảo

MacMahon, 1990, Blood pressure, stroke, and coronary heart disease: part I, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias, Lancet, 335, 765, 10.1016/0140-6736(90)90878-9

Berkson, 1950, Are there two regressions?, J Am Stat Assoc, 45, 164, 10.2307/2280676

Fletcher, 1976, The natural history of chronic bronchitis and emphysema.

Harrington, 1959, Results of treatment of malignant hypertension, Br Med J, ii, 969, 10.1136/bmj.2.5158.969

Sokolow, 1960, Five-year survival of consecutive patients with malignant hypertension treated with antihypertensive agents, Am J Cardiol, 6, 858, 10.1016/0002-9149(60)90285-X

Mohler, 1960, Five-year survival of patients with malignant hypertension treated with antihypertensive agents, Am Heart J, 60, 329, 10.1016/0002-8703(60)90190-3

Bjork, 1961, The effect of active drug treatment in severe antihypertensive disease, Acta Med Scand, 169, 673, 10.1111/j.0954-6820.1961.tb07878.x

Hodge, 1961, Results of hypotensive therapy in arterial hypertension: based on experience with 497 patients treated and 156 controls, observed for periods of one to eight years, Br Med J, 1, 1, 10.1136/bmj.1.5218.1

Perera, 1960, Antihypertensive drug versus symptomatic treatment in primary hypertension, JAMA, 173, 11, 10.1001/jama.1960.03020190013003

Veterans Administration Cooperative Study Group on Antihypertensive Agents, 1967, Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 115 through 129 mm Hg, JAMA, 202, 1028, 10.1001/jama.202.11.1028

Wolff, 1966, Effects of treatment in hypertension: results of a controlled study, J Chron Dis, 19, 227, 10.1016/0021-9681(66)90128-7

Hamilton, 1964, The role of blood-pressure control in preventing complications of hypertension, Lancet, i, 235, 10.1016/S0140-6736(64)92344-X

Report of the British Hypertension Society working party, 1989, Treating mild hypertension. Agreement from the large trials, Br Med J, 298, 694

World Health Organisation/International Society of Hypertension, Mild Hypertension Liaison Committee, 1982, Trials of the treatment of mild hypertension: an interim analysis, Lancet, i, 149

Toth, 1983, Conflicting clinical trials and the uncertainty of treating mild hypertension, Am J Med, 75, 482, 10.1016/0002-9343(83)90354-6

Beevers, 1981, The treatment of mild hypertension: a review, Eur Heart J, 2, 361, 10.1093/oxfordjournals.eurheartj.a061220

Wilcox, 1986, Treatment of high blood pressure: should clinical practice be based on results of clinical trials?, Br Med J, 293, 433, 10.1136/bmj.293.6544.433

1988, Secondary prevention of vascular disease by prolonged antiplatelet treatment, Br Med J, 296, 320, 10.1136/bmj.296.6618.320

Yusuf, 1985, Beta-blockade during and after myocardial infarction: an overview of the randomized trials, Prog Cardiovasc Dis, 27, 335, 10.1016/S0033-0620(85)80003-7

First report of the Early Breast Cancer Trialists Collaborative Group. Adjuvant endocrine and cytotoxic therapy in early breast cancer: a systematic overview of all available randomized trials, NCI Monograph ((in press)).

Sacks, 1985, Should mild hypertension be treated? An attempted meta-analysis of the clinical trials, Mount Sinai J Med, 52, 265

Hebert, 1988, The community-based randomized trials of pharmacologic treatment of mild-to-moderate hypertension, Am J Epidemiol, 127, 581, 10.1093/oxfordjournals.aje.a114833

MacMahon, 1986, The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials, Prog Cardiovasc Dis, 24, 99, 10.1016/0033-0620(86)90038-1

US Public Health Service Hospitals Cooperative Study Group (Smith WM), 1977, Treatment of mild hypertension: results of a ten-year intervention trial, Circ Res, 40, 98

Veterans Administration/National Heart, Lung and Blood Institute Study Group for Cooperative Studies on Anttihypertensive Therapy: Mild Hypertension (Perry HM), 1977, Treatment of mild hypertension: preliminary results of a two-year feasibility trial, Circ Res, 40, 180

Veterans Administration/National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension, 1978, Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial, Ann NY Acad Sci, 304, 267

Hypertension Detection and Follow-up Proggram Cooperative Group, 1979, Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality in persons with high blood pressure, including mild hypertension, JAMA, 242, 2562, 10.1001/jama.242.23.2562

Hypertension Detection and Follow-up Program Cooperative Group, 1979, Five-year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race-sex and age, JAMA, 242, 2572, 10.1001/jama.242.23.2572

Hypertension Detection and Follow-up Program Cooperative Group, 1982, Five-year findings of the Hypertension Detection and Follow-up Program. III. Reduction in stroke incidence among persons with high blood pressure, JAMA, 247, 633, 10.1001/jama.247.5.633

Hypertension Detection and Follow-up Program Cooperative Group, 1982, The effect of treatment on mortality in "mild" hypertension, N Engl J Med, 307, 976, 10.1056/NEJM198210143071603

Hypertension Detection and Follow-up Program Cooperative Group, 1984, Effect of stepped care on the incidence of myocardial infarction and angina pectoris, Hypertension, 6, 198

Helgeland, 1980, Treatment of mild hypertension: a five-year controlled drug trial. The Oslo Study, Am J Med, 69, 725, 10.1016/0002-9343(80)90438-6

Leren, 1986, Oslo hypertension study, Drugs, 31, 41, 10.2165/00003495-198600311-00008

Australian National Blood Pressure Management Committee, 1980, The Australian therapeutic trial in mild hypertension, Lancet, i, 1261

Medical Research Council Working Party, 1985, MRC trial of treatment of mild hypertension: principal results, Br Med J, 291, 97, 10.1136/bmj.291.6488.97

Hypertension-Stroke Cooperative Study Group, 1974, Effect of antihypertensive treatment on stroke recurrence, JAMA, 229, 409, 10.1001/jama.229.4.409

Veterans Administration Cooperative Study Group on Antihypertensive Agents, 1970, Effects of treatment on morbidity in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg, JAMA, 213, 1143, 10.1001/jama.213.7.1143

Barraclough, 1973, Control of moderately raised blood pressure: report of a co-operative randomised controlled trial, Br Med J, iii, 434

Amery, 1985, Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial, Lancet, i, 1349, 10.1016/S0140-6736(85)91783-0

Coope, 1986, Randomised trial of treatment of hypertension in the elderly in primary care, Br Med J, 293, 1145, 10.1136/bmj.293.6555.1145

Carter, 1970, Hypotensive therapy in stroke survivors, Lancet, i, 485, 10.1016/S0140-6736(70)91577-1

Peto, 1985, Cholesterol-lowering trial results in their epidemiologic context, Circulation, 72, 451

Kuramoto, 1981, Prospective study on the treatment of mild hypertension in the aged, Jap Heart J, 22, 75, 10.1536/ihj.22.75

Morgan, 1980, Failure of therapy to improve prognosis in elderly males with hypertension, Med J Aust, ii, 27, 10.5694/j.1326-5377.1980.tb131808.x

Hjermann, 1981, Effects of diet and smoking intervention on the incidence of coronary heart disease, Lancet, ii, 1303, 10.1016/S0140-6736(81)91338-6

Multiple Risk Factor Intervention Trial Research Group, 1982, Multiple risk factor intervention trial. Risk factor changes and mortality results, JAMA, 248, 1465, 10.1001/jama.248.12.1465

Wilhelmsen, 1986, The multi-factor primary prevention trial in Goteborg, Sweden, Eur Heart J, 7, 278, 10.1093/oxfordjournals.eurheartj.a062065

1986, European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6-year results, Lancet, i, 869

1985, Cardiovascular risk and risk factors in a randomised trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH), J Hypenens, 3, 379

Wilhelrnsen, 1987, Beta-blockers versus diuretics in hypertensive men. Main results from the HAPPHY trial, J Hypertens, 5, 561, 10.1097/00004872-198710000-00009

World Health Organisation Regional Office for Europe, 1976

Miall, 1987

1960, Arch Intern Med, 106, 81, 10.1001/archinte.1960.03820010083013

1962, Arch Intern Med, 110, 126

1962, Arch Intern Med, 110, 134

Sprackling, 1981, Blood pressure reduction in the elderly: a randomised controlled trial of methyldopa, Br Med J, 283, 1151, 10.1136/bmj.283.6300.1151

Mantel, 1959, Statistical aspects of the analysis of data from retrospective studies of disease, J Natl Cancer Inst, 22, 719

Collins, 1987, Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews, Stat Med, 6, 245, 10.1002/sim.4780060308

1988, Randomised tnal of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction, Lancet, ii, 349

Cutler, 1989, Controlled clinical trials of drug treatment for hypertension. A review, Hypertension, 13, 36, 10.1161/01.HYP.13.5_Suppl.I36

Holland, 1981, Diuretic-induced ventricular ectopic activity, Am J Med, 70, 762, 10.1016/0002-9343(81)90530-1

Papademetriou, 1983, Diuretic-induced hypokalemia in uncomplicated systemic hypertension: Effect of plasma potassium correction on cardiac arrhythmias, Am J Cardiol, 52, 1017, 10.1016/0002-9149(83)90523-4

Ames, 1976, Elevation of serum lipid levels during diuretic therapy of hypertension, Am J Med, 61, 748, 10.1016/0002-9343(76)90156-X

Grimm, 1981, Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients, Ann Intern Med, 94, 7, 10.7326/0003-4819-94-1-7

Johnson, 1982, The emerging problem of plasma lipid changes during antihypertensive therapy, J Cardiol Pharmacol, 4, 5213, 10.1097/00005344-198200042-00006

Wiedmann, 1983, Effects of antihypertensive therapy on serum lipoproteins, Hypertension, 5, 120

Wiedmann, 1985, Antihypertensive treatment and serum lipoproteins, J Hypertension, 3, 297, 10.1097/00004872-198508000-00001

Pollare, 1989, A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension, N Engl J Med, 321, 868, 10.1056/NEJM198909283211305

Curb, 1986, Adverse effects of antihypertensive medications in the Hypertension Detection and Follow-up Program, Prog Cardiovasc Dis, 29, 73, 10.1016/0033-0620(86)90036-8

Held, 1989, Calcium channel blockers in acute myocardial infarction and unstable angina: an overview, Br Med J, 299, 1187, 10.1136/bmj.299.6709.1187

Beta-Blocker Heart Attack Trial Research Group, 1982, A randomized trial of propranolol in patients with acute myocardial infarction, JAMA, 247, 1717

Norwegian Multicenter Study Group, 1981, Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction, N Engl J Med, 304, 801, 10.1056/NEJM198104023041401

Multicentre International Study, 1977, Supplementary report: Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade, Br Med J, ii, 419

European Infarction Study Group, 1984, A secondary prevention study with slow release oxprenolol after myocardial infarction. Morbidity and mortality, Eur Heart J, 5, 189

The Multicenter Diltiazem Postinfarction Trial Research Group, 1988, The effect of diltiazem on mortality and reinfarction after myocardial infarction, N Engl J Med, 319, 385, 10.1056/NEJM198808183190701

The BBPP Research Group, 1988, The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients, Eur Heart J, 9, 8, 10.1093/ehj/9.1.8

Cruickshank, 1987, Benefits and potential harm of lowering high blood pressure, Lancet, i, 581, 10.1016/S0140-6736(87)90231-5

Cruickshank, 1988, Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction, Br Med J, 297, 1227, 10.1136/bmj.297.6658.1227

Berglund, 1981, Beta-blockers or diuretics in hypertension? A six-year follow-up of blood pressure and metabolic side effects, Lancet, i, 744, 10.1016/S0140-6736(81)92624-6

1982, JAMA, 248, 2004, 10.1001/jama.248.16.2004

Yusuf, 1984, Why do we need some large, simple randomized trials?, Stat Med, 3, 409, 10.1002/sim.4780030421

Hypertension Detection and Follow-up Program Study Group, 1977, The hypertension detection and follow-up program: a progress report, Circ Res, 40, 1106

Hennekens, 1989, Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease, Circulation, 80, 749, 10.1161/01.CIR.80.4.749

UK-TIA Study Group, 1988, United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results, Br Med J, 296, 316, 10.1136/bmj.296.6618.316